https://pipelinereview.com/eluminex-biosciences-announces-fda-acceptance-of-investigational-new-drug-ind-application-for-eb-105-a-novel-trispecific-fusion-antibody-for-diabetic-macular-edema-dme-and-upcoming-scientific/